Pathology and Oncology Research Publishes Landmark Phase 3 Study: Multikine Immunotherapy Significantly Improves Survival and Quality of Life in Head and Neck Cancer Patients
Recent advancements in cancer immunotherapy have brought promising news for patients battling head and neck squamous cell carcinoma…